GLIMPSE GROUP INC/THE (VRAR)

US37892C1062 - Common Stock

1.17  +0.01 (+0.86%)

After market: 1.17 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to VRAR. VRAR was compared to 86 industry peers in the IT Services industry. The financial health of VRAR is average, but there are quite some concerns on its profitability. While showing a medium growth rate, VRAR is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year VRAR has reported negative net income.
VRAR had a negative operating cash flow in the past year.
VRAR had negative earnings in each of the past 5 years.
VRAR had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -114.83%, VRAR is not doing good in the industry: 94.05% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -171.30%, VRAR is doing worse than 78.57% of the companies in the same industry.
Industry RankSector Rank
ROA -114.83%
ROE -171.3%
ROIC N/A
ROA(3y)-107.43%
ROA(5y)-168.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

VRAR has a Gross Margin of 65.93%. This is amongst the best in the industry. VRAR outperforms 82.14% of its industry peers.
VRAR's Gross Margin has improved in the last couple of years.
VRAR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.09%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

VRAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VRAR has been increased compared to 1 year ago.
There is no outstanding debt for VRAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

VRAR has an Altman-Z score of -2.84. This is a bad value and indicates that VRAR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of VRAR (-2.84) is worse than 85.71% of its industry peers.
There is no outstanding debt for VRAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.84
ROIC/WACCN/A
WACC10.77%

2.3 Liquidity

VRAR has a Current Ratio of 1.19. This is a normal value and indicates that VRAR is financially healthy and should not expect problems in meeting its short term obligations.
VRAR's Current ratio of 1.19 is on the low side compared to the rest of the industry. VRAR is outperformed by 64.29% of its industry peers.
A Quick Ratio of 1.19 indicates that VRAR should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.19, VRAR is doing worse than 63.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19

5

3. Growth

3.1 Past

The earnings per share for VRAR have decreased strongly by -220.44% in the last year.
VRAR shows a small growth in Revenue. In the last year, the Revenue has grown by 2.72%.
VRAR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 90.50% yearly.
EPS 1Y (TTM)-220.44%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-163.29%
Revenue 1Y (TTM)2.72%
Revenue growth 3Y90.5%
Revenue growth 5YN/A
Revenue growth Q2Q-29.61%

3.2 Future

Based on estimates for the next years, VRAR will show a very strong growth in Earnings Per Share. The EPS will grow by 33.56% on average per year.
VRAR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.65% yearly.
EPS Next Y48.65%
EPS Next 2Y33.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.62%
Revenue Next 2Y8.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

VRAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VRAR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as VRAR's earnings are expected to grow with 33.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.56%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

VRAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GLIMPSE GROUP INC/THE

NASDAQ:VRAR (5/1/2024, 3:44:33 PM)

After market: 1.17 0 (0%)

1.17

+0.01 (+0.86%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap19.66M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -114.83%
ROE -171.3%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 65.93%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-220.44%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y48.65%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.72%
Revenue growth 3Y90.5%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y